Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


Back to All Announcements
Previous Previous Next Next

Call for papers

Call for papers for a special issue on the epidemiology of leishmaniasis in Europe

Eurosurveillance invites authors to submit papers for a special issue on the surveillance and epidemiology of leishmaniasis in Europe.

Leishmaniasis, a vector-borne disease transmitted by sand flies, is endemic in southern European countries. Autochthonous cases in Europe are mainly due to infection with Leishmania infantum, which causes zoonotic visceral and cutaneous leishmaniasis. L. tropica, endemic only in Greece with a sporadic pattern, causes anthroponotic cutaneous leishmaniasis. Dogs are the main reservoir for L. infantum. Most reported cases have visceral leishmaniasis. A publication in 2008, in Emerging Infectious Diseases [1], estimated that annually around 700 new clinical cases of leishmaniasis are reported in European Union (EU) countries. Asymptomatic cases are thought to be many more, with an estimated ratio of >100 asymptomatic:1 clinical case [2]. Many of the EU countries where the disease is endemic are tourist destinations and there is evidence that a number of leishmaniasis cases diagnosed in non-endemic countries are imported from within the continent. The disease is notifiable in a number of endemic and non-endemic countries in Europe; however, surveillance varies and under-reporting appears to be frequent, especially for the benign forms of cutaneous leishmaniasis.

The aim of the special issue is to contribute to the existing body of evidence and to make available data that can help paint a better picture of the epidemiological situation and burden of autochthonous leishmaniasis in Europe.

We invite interested scientists and public health experts to share their surveillance data, findings and views and submit original papers for peer review and possible publication.

Topics of interest include, but are not limited to:

  • results from surveillance of visceral and cutaneous leishmaniasis in endemic and non-endemic countries, including trends in age groups affected and the impact of HIV co-infection, organ transplantation, and therapies of immunological disorders on the development and outcome of disease;
  • information on the distribution of the vector and reservoir;
  • analysis of treatment-associated costs;
  • control measures implemented successfully to stop the spread of disease;
  •  issues related to the detection and identification of cases.

The submission deadline is 15 July 2012. If you would to submit a paper or ask for more information, please see our instructions for authors regarding article formats: http://www.eurosurveillance.org/Public/ForAuthors/ForAuthors.aspx#article and contact the editorial team at eurosurveillance@ecdc.europa.eu.


References

  1. Dujardin JC, Campino L, Cañavate C, Dedet JP, Gradoni L, Soteriadou K, et al. Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis. 2008;14(7):1013-8.
  2. Michel G, Pomares C, Ferrua B, Marty P. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 2011;119(2-3):69-75.


Back to All Announcements
Previous Previous Next Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.